Selected article for: "congestive heart failure and immune response"
Author: Panchal, Ankur; Kyvernitakis, Andreas; Mikolich, J. Ronald; Biederman, Robert W. W.
Title: Contemporary use of cardiac imaging for COVID-19 patients: a three center experience defining a potential role for cardiac MRI
  • Cord-id: wmiiicis
  • Document date: 2021_2_9
    • ID: wmiiicis
    Snippet: The pandemic of coronavirus disease 2019 (COVID-19) secondary to the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has bestowed an unprecedented challenge upon us, resulting in an international public health emergency. COVID-19 has already resulted in > 1,600,000 deaths worldwide and the fear of a global economic collapse. SARS-CoV-2 is notorious for causing acute respiratory distress syndrome, however emerging literature suggests various dreaded cardiac manifestations assoc
    Document: The pandemic of coronavirus disease 2019 (COVID-19) secondary to the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has bestowed an unprecedented challenge upon us, resulting in an international public health emergency. COVID-19 has already resulted in > 1,600,000 deaths worldwide and the fear of a global economic collapse. SARS-CoV-2 is notorious for causing acute respiratory distress syndrome, however emerging literature suggests various dreaded cardiac manifestations associated with high mortality. The mechanism of myocardial damage in COVID-19 is unclear but thought to be multifactorial and mainly driven by the host’s immune response (cytokine storm), hypoxemia and direct myocardial injury by the virus. Cardiac manifestations from COVID-19 include but are not limited to, acute myocardial injury, cardiac arrhythmias, congestive heart failure and acute coronary syndrome. Cardiac imaging is paramount to appropriately diagnose and manage the cardiac manifestations of COVID-19. Herein, we present cardiac imaging findings of COVID-19 patients with biomarker and imaging confirmed myocarditis to provide insight regarding the variable manifestations of COVID-19 myocarditis via Cardiac MRI (CMR) coupled with CMR-edema education along with recommendations on how to incorporate advanced CMR into the clinicians’ COVID-19 armamentarium. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10554-020-02139-2) contains supplementary material, which is available to authorized users.

    Search related documents:
    Co phrase search for related documents
    • acute coronary syndrome and admission 10 day: 1, 2
    • acute coronary syndrome and long period: 1
    • acute coronary syndrome and longitudinal study: 1
    • acute coronary syndrome and lv dysfunction: 1, 2
    • acute coronary syndrome and lv systolic dysfunction: 1
    • acute coronary syndrome and lymphocytic myocarditis: 1
    • acute coronary syndrome arrhythmia and admission 10: 1
    • acute coronary syndrome diagnosis and admission 10: 1
    • acute respiratory syndrome and admission 10: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • acute respiratory syndrome and admission 10 day: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute respiratory syndrome and longitudinal monitoring: 1, 2, 3, 4, 5, 6
    • acute respiratory syndrome and longitudinal study design: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute respiratory syndrome and lv dysfunction: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory syndrome and lv ejection fraction: 1, 2, 3, 4
    • acute respiratory syndrome and lv rv diastolic function: 1
    • acute respiratory syndrome and lv systolic dysfunction: 1, 2, 3, 4
    • acute respiratory syndrome and lv systolic function: 1, 2
    • acute respiratory syndrome and lymphocytic infiltrate: 1, 2, 3, 4
    • acute respiratory syndrome and lymphocytic myocarditis: 1, 2, 3, 4